Cleared Traditional

K833842 - RIA COAT DIGOXIN

K833842 is an FDA 510(k) clearance for RIA COAT DIGOXIN, manufactured by Immuno Assay Corp.. The device is a Class 2 Toxicology device with product code DPO cleared through the Traditional 510(k) pathway after a 75-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1984
Decision
75d
Days
Class 2
Risk

K833842 is an FDA 510(k) clearance for the RIA COAT DIGOXIN. Classified as Radioimmunoassay, Digoxin (125-i), Rabbit Antibody, Coated Tube Sep. (product code DPO), Class II - Special Controls.

Submitted by Immuno Assay Corp. (Mchenry, US). The FDA issued a Cleared decision on January 17, 1984 after a review of 75 days - a notably fast clearance cycle.

This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.3320 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K833842

510(k) Number K833842 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 03, 1983
Decision Date January 17, 1984
Days to Decision 75 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
12d faster than avg
Panel avg: 87d · This submission: 75d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DPO Device Classification - Class 2, Special Controls

Product Code DPO Radioimmunoassay, Digoxin (125-i), Rabbit Antibody, Coated Tube Sep.
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.3320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Toxicology devices follow this clearance model.

Regulatory Peers - DPO Radioimmunoassay, Digoxin (125-i), Rabbit Antibody, Coated Tube Sep.

All 13
Devices cleared under the same product code (DPO) and FDA review panel - the closest regulatory comparables to K833842.
IMMULITE DIGOXIN
K914833 · Cirrus Diagnostics, Inc. · Nov 1991
ECLIPSE ICA DIGOXIN
K905719 · Biotope, Inc. · Jan 1991
DIGOXIN/RIA KIT COATED TUBE RADIOIMMUNOASSAY KIT
K864449 · Canadian Bioclinical, Ltd. · Feb 1987
SOPHEIA DIGOXIN EIA KIT
K832163 · Diagnostic Products Corp. · Aug 1983
IMMUCHEM COVALENT-COAT RIA KIT
K830962 · Immuchem Corp. · May 1983
COAT-A-COUNT DIGOXIN RIA
K811932 · Diagnostic Products Corp. · Jul 1981